|
C8ORF38 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.018800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.240000E-01 |
| Normal-vs-Stage2 |
7.378000E-01 |
| Normal-vs-Stage3 |
9.387200E-01 |
| Normal-vs-Stage4 |
1.768230E-02 |
| Stage1-vs-Stage2 |
7.691000E-01 |
| Stage1-vs-Stage3 |
9.978000E-01 |
| Stage1-vs-Stage4 |
6.003300E-03 |
| Stage2-vs-Stage3 |
7.885000E-01 |
| Stage2-vs-Stage4 |
1.299350E-01 |
| Stage3-vs-Stage4 |
2.362100E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.118000E-01 |
| Normal-vs-AfricanAmerican |
5.330200E-01 |
| Normal-vs-Asian |
3.461400E-01 |
| Caucasian-vs-AfricanAmerican |
7.099600E-01 |
| Caucasian-vs-Asian |
2.197600E-01 |
| AfricanAmerican-vs-Asian |
2.294800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.019400E-01 |
| Normal-vs-Female |
7.333000E-01 |
| Male-vs-Female |
9.083600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.245800E-01 |
| Normal-vs-Age(41-60Yrs) |
8.642000E-01 |
| Normal-vs-Age(61-80Yrs) |
4.965400E-01 |
| Normal-vs-Age(81-100Yrs) |
3.857600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.587400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.734200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.094600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.280800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.038200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.937400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.456100E-02 |
| Classical-VS-Follicular |
1.098220E-03 |
| Classical-VS-Other |
4.788200E-01 |
| Classical-VS-Normal |
3.949800E-01 |
| Tall-VS-Follicular |
8.359600E-01 |
| Tall-VS-Other |
7.952400E-01 |
| Tall-VS-Normal |
1.890040E-01 |
| Follicular-VS-Other |
7.214600E-01 |
| Follicular-VS-Normal |
6.280400E-02 |
| Other-VS-Normal |
6.280200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.185200E-01 |
| Normal-vs-N1 |
3.365600E-01 |
| N0-vs-N1 |
4.824000E-01 |
|
|
